Carisma to Present First Results From in vivo CAR-M Collaboration with Moderna at SITC 2023
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...
Source: prnewswire.com